74 related articles for article (PubMed ID: 3142401)
1. [Prevalence of arterial hypertension and its treatment in 2,595 adults].
Jouve R; Ebagosti A; Blanc MM; Costa G; Serradimigni A; Jouve A
Arch Mal Coeur Vaiss; 1988 Jun; 81 Spec No():159-64. PubMed ID: 3142401
[TBL] [Abstract][Full Text] [Related]
2. [Profile on circadian blood pressure and the influencing factors in essential hypertensive patients after treatment].
Qiu YG; Yao XY; Tao QM; Zheng P; Chen JZ; Zhu JH; Zhang FR; Zheng LR; Zhao LL
Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Aug; 25(8):710-4. PubMed ID: 15555399
[TBL] [Abstract][Full Text] [Related]
3. Metabolic factors clustering, lipoprotein cholesterol, apolipoprotein B, lipoprotein (a) and apolipoprotein E phenotypes in premature coronary artery disease in French Canadians.
Weber M; McNicoll S; Marcil M; Connelly P; Lussier-Cacan S; Davignon J; Latour Y; Genest J
Can J Cardiol; 1997 Mar; 13(3):253-60. PubMed ID: 9117913
[TBL] [Abstract][Full Text] [Related]
4. Distribution of blood pressure and prevalence of hypertension in Tehran adult population: Tehran Lipid and Glucose Study (TLGS), 1999-2000.
Azizi F; Ghanbarian A; Madjid M; Rahmani M
J Hum Hypertens; 2002 May; 16(5):305-12. PubMed ID: 12082490
[TBL] [Abstract][Full Text] [Related]
5. Prevalence and determinants of undertreatment of hypertension in the Netherlands.
Schelleman H; Klungel OH; Kromhout D; de Boer A; Stricker BH; Verschuren WM
J Hum Hypertens; 2004 May; 18(5):317-24. PubMed ID: 15103311
[TBL] [Abstract][Full Text] [Related]
6. [Prevalence of hypertension in the population of the right-bank Warsaw districts based on research from the Pol-Monica study].
Wagrowska H; Rywik S
Wiad Lek; 1990 Jan 1-15; 43(1-2):47-55. PubMed ID: 2368385
[TBL] [Abstract][Full Text] [Related]
7. [Prevalence, treatment and control of hypertension in family practice patients in France during 1994].
Poggi L; Chamontin B; Lang T; Menard J; Chevalier H; Gallois H; Cremier O
Arch Mal Coeur Vaiss; 1996 Aug; 89(8):1075-80. PubMed ID: 8949382
[TBL] [Abstract][Full Text] [Related]
8. Prevalence, awareness, treatment and control of hypertension in employees of factories of Northern Greece: the Naoussa study.
Sarafidis PA; Lasaridis A; Gousopoulos S; Zebekakis P; Nikolaidis P; Tziolas I; Papoulidou F
J Hum Hypertens; 2004 Sep; 18(9):623-9. PubMed ID: 15029221
[TBL] [Abstract][Full Text] [Related]
9. Blood pressure levels and the treatment of hypertension in Auckland, 1982.
Jackson RT; Beaglehole R; Stewart AW
N Z Med J; 1983 Oct; 96(741):751-4. PubMed ID: 6604888
[TBL] [Abstract][Full Text] [Related]
10. Reverse white-coat effect as an independent risk for microalbuminuria in treated hypertensive patients.
Kato T; Horio T; Tomiyama M; Kamide K; Nakamura S; Yoshihara F; Nakata H; Nakahama H; Kawano Y
Nephrol Dial Transplant; 2007 Mar; 22(3):911-6. PubMed ID: 17142262
[TBL] [Abstract][Full Text] [Related]
11. [Arterial hypertension difficult to control in the elderly patient. The significance of the "white coat effect"].
Amado P; Vasconcelos N; Santos I; Almeida L; Nazaré J; Carmona J
Rev Port Cardiol; 1999 Oct; 18(10):897-906. PubMed ID: 10590654
[TBL] [Abstract][Full Text] [Related]
12. Cardiovascular risk factors and lipoprotein profile in French Canadians with premature CAD: impact of the National Cholesterol Education Program II.
McNicoll S; Latour Y; Rondeau C; Bouthillier D; Davignon J; Genest J
Can J Cardiol; 1995 Feb; 11(2):109-16. PubMed ID: 7866933
[TBL] [Abstract][Full Text] [Related]
13. [Prevalence, awareness, treatment and control of hypertension in Chinese adults].
Gu DF; Jiang H; Wu XG; Reynolds K; Gan WQ; Liu DH; Su SY; Duan XF; Huang GY; Whelton PK
Zhonghua Yu Fang Yi Xue Za Zhi; 2003 Mar; 37(2):84-9. PubMed ID: 12839656
[TBL] [Abstract][Full Text] [Related]
14. Usefulness of the alpha1-blocker doxazosin as a third-line antihypertensive drug.
Ohta Y; Tsuchihashi T; Onaka U; Eto K; Ueno M
Hypertens Res; 2007 Apr; 30(4):301-6. PubMed ID: 17541208
[TBL] [Abstract][Full Text] [Related]
15. Spurious systolic hypertension in young adults; prevalence of high brachial systolic blood pressure and low central pressure and its determinants.
Hulsen HT; Nijdam ME; Bos WJ; Uiterwaal CS; Oren A; Grobbee DE; Bots M
J Hypertens; 2006 Jun; 24(6):1027-32. PubMed ID: 16685201
[TBL] [Abstract][Full Text] [Related]
16. Isolated systolic hypertension: data on a cohort of young subjects from a French working population (IHPAF).
Mallion JM; Hamici L; Chatellier G; Lang T; Plouin PF; De Gaudemaris R
J Hum Hypertens; 2003 Feb; 17(2):93-100. PubMed ID: 12574786
[TBL] [Abstract][Full Text] [Related]
17. [Hypertension in hemodialysis: prevalence and associated factors in Catalonia. The PRESDIAL study].
Poch E; Martinez X; Rodrigo JA; Tovar JL;
Nefrologia; 2006; 26(5):564-72. PubMed ID: 17117899
[TBL] [Abstract][Full Text] [Related]
18. Treatment and blood pressure control in isolated systolic hypertension vs diastolic hypertension in primary care.
Fagard RH; Van den Enden M
J Hum Hypertens; 2003 Oct; 17(10):681-7. PubMed ID: 14504626
[TBL] [Abstract][Full Text] [Related]
19. Association of physician's sex with risk factor control in treated hypertensive patients from Swedish primary healthcare.
Journath G; Hellénius ML; Manhem K; Kjellgren KI; Nilsson PM;
J Hypertens; 2008 Oct; 26(10):2050-6. PubMed ID: 18806630
[TBL] [Abstract][Full Text] [Related]
20. Body mass index, blood pressure, diabetes and the risk of anti-hypertensive drug treatment: 12-year follow-up of middle-aged people in eastern Finland.
Jousilahti P; Tuomilehto J; Vartiainen E; Valle T; Nissinen A
J Hum Hypertens; 1995 Oct; 9(10):847-54. PubMed ID: 8576902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
